MRI Coverage Policies Reconsidered By US Medicare Agency
CMS has opened a national coverage analysis for MRI, but the agency does not provide many details as to what prompted the coverage review or what changes it might consider making to covered or noncovered MRI indications.
You may also be interested in...
The US Centers for Medicare and Medicaid Services followed through with a plan to expand its national coverage policy for MRI scans, removing contraindications and clinical-study requirements for patients with pacemakers, implantable cardioverter defibrillators and other cardiac rhythm devices.
Abbott Laboratories and Boston Scientific recently logged approvals that bring the firms closer to parity with Medtronic in being able to market their cardiac rhythm management devices as compatible with MRI scans. But CMS, the US Medicare agency, is currently considering a coverage policy that make so-called "MR-conditional" product labeling less significant.